[关键词]
[摘要]
糖尿病性视网膜病变(diabetic retinopathy,DR)是50岁以上人群主要致盲眼病之一,而糖尿病性黄斑水肿(diabetic maeular edema, DME)则是DR患者视力下降的首要原因。因此其早诊断、早治疗尤为重要。随着前置镜、OCT、FFA、mfERG等的出现,尤其是视网膜厚度、视网膜体积、水肿指数等客观评价黄斑水肿的量化指标,体现了近年视网膜成像技术的新进展。OCT是近年临床应用的一种非接触性、非侵入性、高分辨率的眼科影像学检查,可以对视网膜超微结构进行观察并做定量分析,且技术已相对成熟,成为黄斑水肿诊断的常规检查。激光光凝、雷珠单抗玻璃体腔内注射以及玻璃体手术是现今治疗顽固性黄斑水肿的重要手段。
[Key word]
[Abstract]
Diabetic retinopathy(DR)is one of the main blinding eye diseases for people over the age of 50, and diabetic macular edema(DME)is the leading cause of vision loss is DR patients. The early diagnosis and early treatment is important. As OCT and FFA, mfERG, especially the retinal thickness, volume, retinal edema index quantitative indicators such as objective evaluation of macular edema, embodies the new progress of retinal imaging technology in recent years. OCT is a non-contact clinical application in recent years, noninvasive, high resolution of ophthalmic imaging examination, can do it on retinal ultrastructure observation and quantitative analysis, and the technology is relatively mature, become a routine inspection diagnosis of macular edema. Laser photocoagulation,intravitreous injection with Ranibizumab and vitrectomy is nowadays the important means for the treatment of intractable macular edema.
[中图分类号]
[基金项目]